This transcript has been edited for clarity. Oliver Freudenreich, MD: Hello. I am Dr Oliver Freudenreich. For this Care Cues conversation today, I'm joined by my colleague, Dr Corinne Cather. We're ...

A 2015 study comparing schizophrenia patients who received oral or injectable antipsychotic medications found no difference in relapse rates between the groups. Now, a follow-up study published August ...

John F. Kelly, PhD, of the Recovery Research Institute and Department of Psychiatry at Mass General Brigham, is the lead ...

At Real Recovery Solutions, we cater to individuals grappling with substance abuse and addiction, including those with co-occurring mental health disorders like depression, anxiety, and PTSD. Our ...